1-2 of 2
Nichola McWhirter
Close
Sort by
Journal Articles

Combination of Ibrutinib Plus Venetoclax with MRD-Driven Duration of Treatment Results in a Higher Rate of MRD Negativity in IGHV Unmutated Than Mutated CLL: Updated Interim Analysis of FLAIR Study

Talha Munir, Alexandra Pitchford, Adrian Bloor, Andrew Pettitt, Piers E.M. Patten, Francesco Forconi, Anna Schuh, Christopher P Fox, Simona Gatto, Ben Kennedy, John Gribben, Nicholas Pemberton, Oonagh Sheehy, Gavin Preston, Dena Howard, Anna Hockaday, David Cairns, Sharon Jackson, Natasha Greatorex, Nichola McWhirter, Jane Shingles, Kate Cwynarski, Shankara Paneesha, David Allsup, Andrew Rawstron, Peter Hillmen
Journal: Blood
Blood (2022) 140 (Supplement 1): 231–233.
https://doi.org/10.1182/blood-2022-170463
Published: 2022
Journal Articles

The Activated B-Cell Subtype of Diffuse Large B-Cell Lymphoma As Determined By Whole Genome Expression Profiling on Paraffin Embedded Tissue Is Independently Associated with Reduced Overall and Progression Free Survival in the Rituximab Era: Results from the UK NCRI R-CHOP 14 v 21 Phase III Trial

Mary Gleeson, Andrew Jack, David Cunningham, Nicholas Counsell, Nichola McWhirter, Rebecca Chalkley, Eliza A Hawkes, Nick Chadwick, Anthony Laurie, Paul Smith, Christopher Pocock, Kirit M Ardeshna, John A. Radford, MD, Andrew McMillan, John Davies, Deborah Turner, Anton Kruger, Peter Johnson, Cathy H Burton, David C Linch, Sharon L Barrans
Journal: Blood
Blood (2016) 128 (22): 1746.
https://doi.org/10.1182/blood.V128.22.1746.1746
Published: 2016